Session Schedule
The full and extensive program includes two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research, and other research developments. The ASM program also includes abstracts, debates, and is followed by a two-day trainee and early-career weekend. The theme for the 45th ASM is International Collaboration in Breast Cancer Trials, and we look forward to colleagues joining the meeting.
Introduction to Session
Topic TBD
Speaker: Dr Akihiko Shimomura
Akihiko Shimomura
Using population-based health record linkage to study the incidence and outcomes of metastatic breast cancer
Speaker: Dr Sally Lord
Sally Lord
A Medical Oncologist revisits oligometastatic disease
Speaker: Professor Prue Francis
Prue Francis
A Radiation Oncologist revisits oligometastatic disease
Speaker: Associate Professor Steven David
Steven David
Combined questions for both presentations
Speakers: Professor Prue Francis and Associate Professor Steven David
Steven David
Prue Francis
Afternoon Tea Break
Topic TBD
Genomic testing and therapeutic targets in breast cancer
Speaker: Dr Stephen Luen
Stephen Luen
Molecular Imaging in Breast Cancer
Speaker: Dr Zahra Sabahi
Zahra Sabahi
Close of Day 2 Scientific Sessions and Close ASM
Welcome to Session
Topic TBD
Risk Adjusted Screening in Australia: The role of trials to help progress the Roadmap
Speaker: Associate Professor Carolyn Nickson
Carolyn Nickson
Topic TBD
Speaker: Ms Vicki Durston
Vicki Durston
The key stakeholder perspectives on implementation of risk based screening
Speaker: Dr Jocelyn Lippey
Jocelyn Lippey
Afternoon Tea Break
Surveillance of those with PHBC
Speaker: Dr Julia Matheson
Julia Matheson
Vacuum Assisted Excision of Asymptomatic Breast Lesions
Speaker: Professor Gelareh Farshid
Gelareh Farshid